The NeuroKids Research Laboratory aims to improve the quality of life and communication of children surviving major childhood cancer and acquired brain injury.
We bring together a team of speech pathology experts to conduct a range of clinical research into medical paediatric speech pathology, with the aim of improving the quality of life and communication of children surviving major childhood cancer and acquired brain injury.
Child survivors of brain cancer and leukaemia - the top two most common childhood cancers in Australia and developed countries worldwide - often face a new challenge during and after their cancer treatment is completed.
The Clinical Practice Guidelines for the Management of Communication and Swallowing in Children diagnosed with Childhood Brain Tumour or Leukaemia (pdf, 6.4mb) has been developed to assist health professionals and patient consumers (parents of children with CBTL, survivors of CBTL) to provide and advocate for evidence-based care and management of communication and swallowing in children diagnosed with CBTL.
These guidelines were supported and funded by the Cancer Institute NSW, and approved by the National Health and Medical Research Council (NHMRC) in November 2020. The development of the final recommendations has not been influenced by the views or interests of the funding bodies.
Guideline documents can be accessed here:
Translated guideline summaries:
Supplementary documents include: